+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Contract Research Organization Market to 2025 - Regional Analysis and Forecasts By Type; End User, and Country

  • ID: 4987839
  • Report
  • January 2020
  • Region: Europe
  • 151 pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Charles River
  • ICON plc
  • IQVIA
  • Medpace
  • PRA Health Sciences
  • Syneos Health
  • MORE
Contract research organization (CRO) market in Europe is expected to grow from US$ 12,476.8Mn in the year 2017 and is expected to reach US$ 22,157.62 Mn by 2025 growing at a healthy CAGR for the forecast period.

The growth of the market is driven by factors such as the rise in the number of clinical trials. On the other hand, the dearth of skilled professionals in some of the European countries is limiting the growth of the market is likely to have a negative impact on the market growth in the coming years.

The CRO industry is fragmented, with several hundred small and medium-sized limited-service providers, and a small number of large, full-service, global CROs. There are few barriers for the smaller CROs to entry into the global market, whereas a full-service CRO with global capabilities requires building the necessary infrastructure with the ability to simultaneously manage multiple complex testing services across numerous geographies, establishing the requisite relationships with strategic partners, developing relevant therapeutic and development of expertise to serve the needs of the end-users. Over the past few years, the consolidation in the CRO industry is an emerging trend. It is followed by the majority of the prime players to strengthen their service offerings and garner a significant market share in the regional CRO market. Thus it has led to the availability handful of larger CROs with broad geographic diversification, extensive therapeutic and development expertise, enormous capital and technical resources to manage the demanding drug development programs of pharmaceutical and biopharmaceutical companies.

CRO's service market is creating various opportunities that are leading to the growth of the market and industries. The current going trend in the CRO industry is for the consolidation of the market. Various large players have signed agreements, some of them have merged and acquired different companies. Some of the instances are below.

The secondary sources used for validations and data mining in the Europe contract research organization market includes Pharmaceuticals and Medical Devices Agency (PMDA), Food and Drug Administration (FDA), European Federation of Pharmaceuticals Industries Associations (EFPIA), World Health Organization (WHO), are among the others.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the European contract research organization (CRO) market.
  • Highlights key business priorities to assist companies in realigning their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe contract research organization (CRO) market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth; offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest concerning client products, segmentation, pricing, and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Charles River
  • ICON plc
  • IQVIA
  • Medpace
  • PRA Health Sciences
  • Syneos Health
  • MORE
1. Introduction
1.1 Scope of The Study
1.2 Research Report Guidance

2. Europe Contract Research Organization (CRO) Market - Key Takeaways

3. Europe Contract Research Organization (CRO) Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Contract Research Organization (CRO) Market - By Type
3.2.2 Europe Contract Research Organization (CRO) Market - By End User
3.2.3 Europe Contract Research Organization (CRO) Market - By Country
3.3 Pest Analysis
3.3.1 Europe - PEST Analysis

4. Europe Contract Research Organization (CRO) Market-Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rise in The Number of Clinical Trials
4.2 Key Market Restraints
4.2.1 Dearth Of Skilled Professionals
4.2.2 Regional Competition in The CRO Services Market
4.3 Key Market Opportunities.
4.3.1 Increasing Demand for Specialized Testing Services
4.4 Future Trends
4.4.1 Increasing Market Consolidation
4.5 Impact Analysis

5. Contract Research Organization (CRO) Market - Europe Analysis
5.1 Europe Contract Research Organization (CRO) Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
5.4 Expert Opinions

6. Europe Contract Research Organization (CRO) Market Analysis - By Type
6.1 Overview
6.2 Europe Contract Research Organization (CRO) Market, By Type 2017 & 2025 (%)
6.3 Europe Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By Type (US$ Mn)
6.4 Early Phase Development Services Market
6.4.1 Overview
6.4.2 Europe Early Phase Development Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.4.3 Drug Discovery Services
6.4.3.1 Overview
6.4.3.2 Europe Drug Discovery Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.4.4 Pre-Clinical Services
6.4.4.1 Overview
6.4.4.2 Europe Pre-Clinical Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 Clinical Research Services
6.5.1 Overview
6.5.2 Europe Clinical Research Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 Laboratory Services
6.6.1 Overview
6.6.2 Europe Laboratory Services Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 Post-Approval Services
6.7.1 Overview
6.7.2 Europe Post-Approval Services Market Revenue and Forecasts to 2025 (US$ Mn)

7. Europe Contract Research Organization (CRO) Market Analysis - By End User
7.1 Overview
7.2 Europe Contract Research Organization (CRO) Market, By End User, 2017 & 2025 (%)
7.3 Europe Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By End User (US$ Mn)
7.4 Pharmaceutical And Biotechnology Companies
7.4.1 Overview
7.4.2 Europe Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 Medical Device Companies
7.5.1 Overview
7.5.2 Europe Medical Device Companies Market Revenue and Forecasts to 2025 (US$ Mn)

8. Europe Contract Research Organization (CRO) Market Revenue and Forecasts to 2025
8.1 Overview
8.2 Europe Contract Research Organization (CRO) Market Revenue and Forecasts to 2025 (Us$ Mn)
8.3 Europe Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By Type (US$ Mn)
8.3.1 Europe Early Phase Development Services Market Revenue and Forecasts to 2025, By Type (US$ Mn)
8.4 Europe Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By End User (US$ Mn)
8.5 Europe Contract Research Organization (CRO) Market Share, By Country (2017 & 2025) (%)
8.6 Germany Contract Research Organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.6.1 Germany Contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.6.2 Germany Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By Type (US$ Mn)
8.6.2.1 Germany Early Phase Development Services Market Revenue and Forecasts to 2025, By Type (US$ Mn)
8.6.3 Germany Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By End User (US$ Mn)
8.7 UK Contract Research Organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.7.1 UK Contract research organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.7.2 UK Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By Type (US$ Mn)
8.7.2.1 UK Early Phase Development Services Market Revenue and Forecasts to 2025, By Type (US$ Mn)
8.7.3 UK Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By End User (US$ Mn)
8.8 France Contract Research Organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.8.1 France Contract Research Organization (CRO) Market Revenue and Forecasts to 2025 (US$ Mn)
8.8.2 France Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By Type (US$ Mn)
8.8.2.1 France Early Phase Services Market Revenue and Forecasts to 2025, By Type (US$ Mn)
8.8.3 France Contract Research Organization (CRO) Market Revenue and Forecasts to 2025, By End User (US$ Mn)

9. Contract Research Organization (CRO) Market -Industry Landscape
9.1 Overview
9.2 Growth Strategies In The Contract Research Organization (CRO) Market, 2015-2018
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.3.2 Merger & Acquisitions
9.3.3 Collaborations
9.3.4 Partnership
9.3.5 Alliance
9.3.6 Agreement & Joint Venture
9.4 Organic Growth Strategies
9.4.1 Overview
9.4.2 Launch
9.4.3 Expansion & Relocation
9.4.4 Enhancements

10. Contract Research Organization (CRO) Market - Key Company Profiles
10.1 Iqvia
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Information
10.1.4 Service Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Parexel International Corporation
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Service Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Syneos Health
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Information
10.3.4 Service Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Laboratory Corporation Of America Holdings
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Service Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Pra Health Sciences, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Overview
10.5.4 Service Portfolio
10.5.5 Swot Analysis
10.5.6 Key Developments
10.6 Charles River
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Service Portfolio
10.6.5 Swot Analysis
10.6.6 Key Developments
10.7 ICON Plc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Service Portfolio
10.7.5 Swot Analysis
10.7.6 Key Developments
10.8 Pharmaceutical Product Development, Llc.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Service Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Wuxi Apptec
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Service Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Medpace
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Service Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments

11. Appendix
11.1 About the Publisher
11.2 Glossary Of Terms
11.3 Methodology
11.4 Coverage
11.5 Secondary Research
11.6 Primary Research
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • IQVIA
  • Laboratory Corporation of America Holdings
  • PAREXEL International Corporation
  • ICON plc
  • Syneos Health
  • PRA Health Sciences
  • Charles River
  • Pharmaceutical Product Development, LLC
  • WuXi AppTec
  • Medpace
Note: Product cover images may vary from those shown
Adroll
adroll